Ana Cecilia Luque-Badillo

Mrs. Ana Cecilia Luque-Badillo

Urologic sciences, University of British Columbia, Vancouver, British Columbia, Canada
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CACesar Ulises Monjaras Avila
Cesar Ulises Monjaras Avila
ALAna Cecilia Lorenzo-Leal
Ana Cecilia Lorenzo-Leal
ALAna Cecilia Luque-Badillo
Ana Cecilia Luque-Badillo
NDNinadh D’costa
Ninadh D’costa
CCClaudia Chavez-Munoz
Claudia Chavez-Munoz
Horacio BachHoracio Bach
Horacio Bach
Clear cell renal cell carcinoma (ccRCC) is a type of kidney cancer that arises from the cells lining the tubes of the kidney. The tumor immune microenvironment (TIME) of ccRCC is a complex interplay of various immune cells, cytokines, and signaling pathways. One of the critical features of the ccRCC TIME is the presence of infiltrating immune cells, including T cells, B cells, natural killer cells, dendritic cells, and myeloid-derived suppressor cells. Among these cells, CD8+ T cells are particularly important in controlling tumor growth by recognizing and killing cancer cells. However, the TIME of ccRCC is also characterized by an immunosuppressive environment that hinders the function of immune cells. Several mechanisms contribute to the immunosuppressive nature of the ccRCC TIME. For instance, ccRCC cells produce cytokines such as interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β), which suppress immune cell activation and promote the differentiation of regulatory T cells (Tregs). Tregs, in turn, dampen the activity of effector T cells and promote tumor growth. In addition, ccRCC cells can express programmed death-ligand 1 (PD-L1), which interacts with the programmed cell death protein 1 (PD-1) receptor on T cells to inhibit their function. In addition, other immune checkpoint proteins, such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and lymphocyte activation gene 3 (LAG-3), also contribute to the immunosuppressive milieu of the ccRCC TIME. Finally, the hypoxic and nutrient-poor microenvironment of ccRCC can stimulate the production of immunosuppressive metabolites, such as adenosine and kynurenine, which further impair the function of immune cells. Understanding the complex interplay between tumor cells and the immune system in the ccRCC TIME is crucial for developing effective immunotherapies to treat this disease.

4 November 2024 in Research in Science & Technological Education
Verified
Journal Article
Closed access
MGMartin Garcia-Gonzalez
Martin Garcia-Gonzalez
KCKaren Ivana Caro-Felix
Karen Ivana Caro-Felix
DBDiana Priscila Bonilla-Ruelas
Diana Priscila Bonilla-Ruelas
ACAlan Maximiliano Cortes-Limon
Alan Maximiliano Cortes-Limon
ALAna Cecilia Luque-Badillo
Ana Cecilia Luque-Badillo
CRClara Patricia Rios-Ibarra
Clara Patricia Rios-Ibarra